Methods |
Randomized, double blinded, placebo‐controlled trial |
Participants |
Cardiac surgery |
Interventions |
N‐acetylcysteine 50 mg/kg bolus preoperatively then 50 mg/kg/day for 48 hrs versus placebo (0.9% NaCl) |
Outcomes |
markers of myocardial injury |
Notes |
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Only stated: patients were randomized. |
Allocation concealment (selection bias) |
Unclear risk |
Not described. |
Blinding (performance bias and detection bias)
All outcomes |
Low risk |
Patients, medical staff and investigators blinded for treatment allocation. |
Selective reporting (reporting bias) |
Low risk |
|
Other bias |
Low risk |
|